Adagrasib (Krazati)

This PQI in Action is a follow up to the Adagrasib (KRAZATI®) PQI and explores how the medically integrated teams at Johns Hopkins Sidney Kimmel Cancer Center and American Oncology Network incorporate the information found in the PQIs as part of their daily workflow. This article will discuss how utilizing the Adagrasib (KRAZATI®) PQI elevates patient care.